Guenter Haines (@guenterhaines) 's Twitter Profile
Guenter Haines

@guenterhaines

Prioritize people and purpose and things tend to work out...

ID: 139285888

linkhttp://reflowmedical.com calendar_today02-05-2010 04:04:37

1,1K Tweet

212 Takipçi

513 Takip Edilen

cobra. (@cobrastats) 's Twitter Profile Photo

Evan Miyakawa I've been hot on the case for a while with Purdue. When Purdue shoots away from home with the Nike ball vs. the Wilson ball - pretty interesting... Jeff Goodman

<a href="/EvanMiya/">Evan Miyakawa</a> I've been hot on the case for a while with Purdue. When Purdue shoots away from home with the Nike ball vs. the Wilson ball - pretty interesting... <a href="/GoodmanHoops/">Jeff Goodman</a>
Basketball HOF (@hoophall) 's Twitter Profile Photo

A 7x Big Ten Coach of the Year with 17 NCAA tournament appearances, he is also a 2013 Collegiate Basketball Hall of Fame inductee. Congratulations to #23HoopClass inductee Gene Keady.

A 7x Big Ten Coach of the Year with 17 NCAA tournament appearances, he is also a 2013 Collegiate Basketball Hall of Fame inductee. Congratulations to #23HoopClass inductee Gene Keady.
Cardiac Dimensions (@carillon_cdi) 's Twitter Profile Photo

By partnering with CardioNerds on the EMPOWER CardioNerds Clinical Trial Network, we allow HF and IC fellows to learn from patient recruitment in our pivotal study of the #CarillonSystem for #heartfailure patients with functional #mitralregurgitation grades I-IV. #cardiotwitter

By partnering with <a href="/CardioNerds/">CardioNerds</a> on the EMPOWER CardioNerds Clinical Trial Network, we allow HF and IC fellows to learn from patient recruitment in our pivotal study of the #CarillonSystem for #heartfailure patients with functional #mitralregurgitation grades I-IV.
#cardiotwitter
Cardiac Dimensions (@carillon_cdi) 's Twitter Profile Photo

Going to TVT? You’re invited to a 6/8 symposium to learn about the EMPOWER Trial studying the Carillon Mitral Contour System® for HF patients with FMR. Hear from Cleveland Clinic, Stanford University and UC San Francisco PIs. See you there! #cardiotwitter #cardiology #heartfailure #mitralvalverepair

Going to TVT? You’re invited to a 6/8 symposium to learn about the EMPOWER Trial studying the Carillon Mitral Contour System® for HF patients with FMR. Hear from <a href="/ClevelandClinic/">Cleveland Clinic</a>, <a href="/Stanford/">Stanford University</a> and <a href="/UCSF/">UC San Francisco</a> PIs. See you there!

#cardiotwitter #cardiology #heartfailure #mitralvalverepair
Cardiac Dimensions (@carillon_cdi) 's Twitter Profile Photo

Is GDMT enough for HF patients with FMR? The EMPOWER Trial is evaluating a device that goes beyond GDMT to see if it can acutely reduce FMR and remodel the heart for long-term benefits. bit.ly/3N5SSB4 #cardiotwitter #heartfailure #mitralvalverepair #mitralregurgitation

Cardiac Dimensions (@carillon_cdi) 's Twitter Profile Photo

Dr. Nabil Dib of Dignity Health reviews safety data from prior international studies of the Carillon Mitral Contour System®, currently being evaluated in the EMPOWER Trial. bit.ly/3WInGuQ #cardiotwitter #heartfailure #mitralvalverepair #mitralregurgitation #cardiology

ReflowMedical (@reflowmedical) 's Twitter Profile Photo

The news is out! We've enrolled the first patients in a pilot study of the Coronary Sirolimus-Eluting Retrievable Scaffold System (Spur Elute) (DEEPER CORONARY, NCT06117150). The Principal Investigator is Dr. Scott Harding, with Dr. Bill Lombardi and Dr. Kathleen E. Kearney, in

The news is out! We've enrolled the first patients in a pilot study of the Coronary Sirolimus-Eluting Retrievable Scaffold System (Spur Elute) (DEEPER CORONARY, NCT06117150). The Principal Investigator is Dr. Scott Harding, with <a href="/DrBillLombardi/">Dr. Bill Lombardi</a> and Dr. Kathleen E. Kearney, in
ReflowMedical (@reflowmedical) 's Twitter Profile Photo

Did you catch them all? Awesome presentations on Spur® RST at #AMPEU, the AMP the CLTI Meeting. We sincerely thank our physician colleagues! 👨‍⚕️ - Prof. Jos van den Berg gave updates on the DEEPER OUS trial, 2-year data. - Dr. Daniel van den Heuvel presented a "Live in a Box" session

Did you catch them all? Awesome presentations on Spur® RST at #AMPEU, the <a href="/AMPSymposium/">AMP the CLTI Meeting</a>. We sincerely thank our physician colleagues! 👨‍⚕️ 

- Prof. Jos van den Berg gave updates on the DEEPER OUS trial, 2-year data. 
- Dr. Daniel van den Heuvel presented a "Live in a Box" session
ReflowMedical (@reflowmedical) 's Twitter Profile Photo

The latest data on tibial vessel recoil after treatment with Spur® RST is now published in the Journal of Endovascular Therapy (JEVT). The study examined the occurrence and short-term impact of acute vessel recoil in a subset of patients treated with retrievable scaffold therapy

The latest data on tibial vessel recoil after treatment with Spur® RST is now published in the Journal of Endovascular Therapy (JEVT). The study examined the occurrence and short-term impact of acute vessel recoil in a subset of patients treated with retrievable scaffold therapy
ReflowMedical (@reflowmedical) 's Twitter Profile Photo

𝗙𝗗𝗔 𝗚𝗥𝗔𝗡𝗧𝗦 𝗗𝗘 𝗡𝗢𝗩𝗢 𝗖𝗟𝗘𝗔𝗥𝗔𝗡𝗖𝗘 𝗙𝗢𝗥 𝗧𝗛𝗘 𝗦𝗣𝗨𝗥® 𝗣𝗘𝗥𝗜𝗣𝗛𝗘𝗥𝗔𝗟 𝗥𝗘𝗧𝗥𝗜𝗘𝗩𝗔𝗕𝗟𝗘 𝗦𝗧𝗘𝗡𝗧 𝗦𝗬𝗦𝗧𝗘𝗠 ❇️ We are proud to announce that our Spur Stent System is now commercially available! Spur is the first and only retrievable stent

𝗙𝗗𝗔 𝗚𝗥𝗔𝗡𝗧𝗦 𝗗𝗘 𝗡𝗢𝗩𝗢 𝗖𝗟𝗘𝗔𝗥𝗔𝗡𝗖𝗘 𝗙𝗢𝗥 𝗧𝗛𝗘 𝗦𝗣𝗨𝗥® 𝗣𝗘𝗥𝗜𝗣𝗛𝗘𝗥𝗔𝗟 𝗥𝗘𝗧𝗥𝗜𝗘𝗩𝗔𝗕𝗟𝗘 𝗦𝗧𝗘𝗡𝗧 𝗦𝗬𝗦𝗧𝗘𝗠 ❇️ 

We are proud to announce that our Spur Stent System is now commercially available! 

Spur is the first and only retrievable stent